Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Ddf Parallel Llp investment portfolio

Ddf Parallel Llp has made numerous investments in companies such as Amphista Therapeutics, Astronautx, and Loqus23 Therapeutics within the Biotech sector.

unknown
Portfolio
7
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (7)

CompanySectorCitySourceLast confirmed on
Alchemab Therapeutics Ltd
Alchemab Therapeutics develops antibody‑based medicines by mining naturally protective antibodies from long‑term disease survivors and other resilient individuals, using deep‑learning and biotechnology platforms to create therapies for cancer, neurodegenerative disorders and infectious diseases.
Healthcare & Life SciencesLondonConfirmed2025-11-28
Amphista Therapeutics Limited
Amphista Therapeutics develops next‑generation targeted protein‑degradation medicines, employing its proprietary “Targeted Glue” technology to create drugs that selectively destroy disease‑causing proteins. Its products are directed at patients with high‑unmet‑need diseases where conventional therapies are insufficient.
Healthcare & Life SciencesCambridgeConfirmed2025-12-06

Sign up to see the full portfolio

+5 more companies

Sign up

Shareholding changes (7)

Ddf Parallel Llp's positions across portfolio companies
2025

Sign up free to see when this investor has bought or sold shares.

+5 more changes

Sign up

Articles (1)